132 related articles for article (PubMed ID: 2702573)
1. A rational postoperative follow-up with carcinoembryonic antigen, tissue polypeptide antigen, and urinary hydroxyproline in breast cancer patients.
Nicolini A; Carpi A; Di Marco G; Giuliani L; Giordani R; Palla S
Cancer; 1989 May; 63(10):2037-46. PubMed ID: 2702573
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients.
Nicolini A; Colombini C; Luciani L; Carpi A; Giuliani L
Br J Cancer; 1991 Jul; 64(1):154-8. PubMed ID: 1854615
[TBL] [Abstract][Full Text] [Related]
3. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases.
Nicolini A; Tartarelli G; Carpi A; Metelli MR; Ferrari P; Anselmi L; Conte M; Berti P; Miccoli P
BMC Cancer; 2006 Nov; 6():269. PubMed ID: 17116247
[TBL] [Abstract][Full Text] [Related]
4. The Role of TPS and TPA in the Diagnostics of Distant Metastases.
Kucera R; Topolcan O; Fiala O; Kinkorova J; Treska V; Zedníková I; Slouka D; Simanek V; Safanda M; Babuska V
Anticancer Res; 2016 Feb; 36(2):773-7. PubMed ID: 26851038
[TBL] [Abstract][Full Text] [Related]
5. The role of tumour markers in predicting skeletal metastases in breast cancer patients with equivocal bone scintigraphy.
Nicolini A; Ferrari P; Sagripanti A; Carpi A
Br J Cancer; 1999 Mar; 79(9-10):1443-7. PubMed ID: 10188888
[TBL] [Abstract][Full Text] [Related]
6. The role of tumour markers in improving the accuracy of conventional chest X-ray and liver echography in the post-operative detection of thoracic and liver metastases from breast cancer.
Nicolini A; Carpi A; Ferrari P; Anselmi L; Spinelli C; Conte M; Miccoli P
Br J Cancer; 2000 Dec; 83(11):1412-7. PubMed ID: 11076646
[TBL] [Abstract][Full Text] [Related]
7. Comparison between CEA, TPA, CA 15/3 and hydroxyproline, alkaline phosphatase, whole body retention of 99mTc MDP in the follow-up of bone metastases in breast cancer.
Francini G; Montagnani M; Petrioli R; Paffetti P; Marsili S; Leone V
Int J Biol Markers; 1990; 5(2):65-72. PubMed ID: 2283479
[TBL] [Abstract][Full Text] [Related]
8. [Clinical study of the measurement of tissue polypeptide antigen in patients with breast cancer].
Fukunaga M; Otsuka N; Yanagi M; Sone T; Muranaka A; Yanagimoto S; Tomomitsu T; Morita R; Ohama T; Sonoo H
Gan No Rinsho; 1985 Jul; 31(8):923-8. PubMed ID: 4032770
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
[TBL] [Abstract][Full Text] [Related]
10. Utility of a serum tumour marker panel in the post-operative follow-up of breast cancer patients with equivocal conventional radiological examinations.
Nicolini A; Carpi A; Ferrari P; Pieri L
Tumour Biol; 2003; 24(6):275-80. PubMed ID: 15004486
[TBL] [Abstract][Full Text] [Related]
11. [Tissue polypeptide and carcinoembryonic antigens in patients with breast cancer].
Polevaia EB; Tkacheva GA; Ivanov VM; Koposova TL
Vopr Onkol; 1984; 30(3):9-13. PubMed ID: 6710954
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of bone and liver metastases in breast cancer comparing tumor markers and imaging techniques.
Zanco P; Rota G; Sportiello V; Borsato N; Ferlin G
Int J Biol Markers; 1989; 4(2):103-5. PubMed ID: 2768888
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis of skeletal metastases by serum tumor markers].
Shinozaki T; Chigira M
Nihon Seikeigeka Gakkai Zasshi; 1991 Aug; 65(8):441-6. PubMed ID: 1720162
[TBL] [Abstract][Full Text] [Related]
14. [The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer].
Schatz C; von Lieven H; Mulders M; Rowold J; Stracke H; Müller H; Grebe SF; Schatz H
Wien Klin Wochenschr; 1985 Dec; 97(23):873-9. PubMed ID: 3878042
[TBL] [Abstract][Full Text] [Related]
15. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
Björklund V; Björklund B
Cancer Detect Prev; 1983; 6(1-2):193-8. PubMed ID: 6883380
[TBL] [Abstract][Full Text] [Related]
16. [The tumor markers TPA and CEA in the after care of breast cancer].
Beaufort F; Fueger GF; Steiner H
Wien Med Wochenschr; 1985 Feb; 135(4):85-8. PubMed ID: 2986366
[TBL] [Abstract][Full Text] [Related]
17. Plasma carcinoembryonic antigen and tissue polypeptide antigen levels in lung cancer: correlation with cell types and stage.
Salvati F; Antilli A; Cruciani AR; Pau F; Flore F; Munno R; De Angelis G; Cipri A; Pigorini F
Cancer Detect Prev; 1985; 8(1-2):111-4. PubMed ID: 4064030
[TBL] [Abstract][Full Text] [Related]
18. [Changes in carcinoembryonic antigen and tissue polypeptide antigen in monitoring the post-operative course of some tumor types].
Ciaccio B; Caponi A; Cappetti P; Fanciullacci A; Bartoli P; Berti P
Quad Sclavo Diagn; 1985 Jun; 21(2):199-205. PubMed ID: 4080962
[TBL] [Abstract][Full Text] [Related]
19. Combination of tissue polypeptide antigen (TPA) and carcino embryonic antigen (CEA) in different types of cancer.
Falcone F; Sabbatani S; Fini A; Turba E; Magri P; D'Ales A
Nucl Med Commun; 1985 May; 6(5):299-304. PubMed ID: 4034127
[TBL] [Abstract][Full Text] [Related]
20. A novel method for monitoring high-risk breast cancer with tumor markers: CA 15.3 compared to CEA and TPA.
Sölétormos G; Nielsen D; Schiøler V; Skovsgaard T; Winkel P; Mouridsen HT; Dombernowsky P
Ann Oncol; 1993 Dec; 4(10):861-9. PubMed ID: 8117606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]